Literature DB >> 10049200

Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients.

M H Nguyen1, C A Kauffman, R P Goodman, C Squier, R D Arbeit, N Singh, M M Wagener, V L Yu.   

Abstract

BACKGROUND: Staphylococcus aureus is a common cause of serious infection in patients infected with HIV.
OBJECTIVES: To evaluate risk factors for and quantitative effect of S. aureus infection in HIV-infected patients, with special attention to nasal carriage.
DESIGN: Prospective, multihospital cohort study.
SETTING: Three tertiary care Veterans Affairs Medical Centers. PARTICIPANTS: 231 ambulatory HIV-infected patients.
RESULTS: Thirty-four percent of patients were nasal carriers of S. aureus. Of these patients, 38% were persistent carriers and 62% were intermittent carriers. Twenty-one episodes of infection occurred in 13 patients: Ten were bacteremias (including 2 cases of endocarditis), 1 was pneumonia, and 10 were cutaneous or subcutaneous infections. Seventeen (85%) of these episodes occurred in patients with CD4 counts less than 100 cells/mm3. Recurrent infections occurred in 3 of 7 patients who survived an initial S. aureus infection. The mortality rate was higher among patients with S. aureus infection than among those without infection (P = 0.03). Factors significantly associated with S. aureus infection were nasal carriage, presence of a vascular catheter, low CD4 count, and neutropenia. Molecular strain typing indicated that for 6 of 7 infected patients, the strain of S. aureus isolated from the infected sites was the same as that previously cultured from the nares.
CONCLUSION: Nasal carriage is an important risk factor for S. aureus infection in HIV-infected patients. Controlled studies are indicated to determine whether eradication of nasal carriage in a selected subset of patients (for example, those with a low CD4 cell count) might prevent invasive S. aureus infection in patients with HIV infection.

Entities:  

Mesh:

Year:  1999        PMID: 10049200     DOI: 10.7326/0003-4819-130-3-199902020-00026

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

1.  Nasal carriage of Staphylococcus aureus on admission to intensive care: incidence and prognostic significance.

Authors:  Richard Porter; Kandasamy Subramani; Antony N Thomas; Paul Chadwick
Journal:  Intensive Care Med       Date:  2003-03-05       Impact factor: 17.440

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection.

Authors:  Kathy Thompson; Francesca Torriani
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

3.  c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation.

Authors:  David K R Karaolis; Mohammed H Rashid; Rajanna Chythanya; Wensheng Luo; Mamoru Hyodo; Yoshihiro Hayakawa
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus.

Authors:  Damian C Melles; Raymond F J Gorkink; Hélène A M Boelens; Susan V Snijders; Justine K Peeters; Michael J Moorhouse; Peter J van der Spek; Willem B van Leeuwen; Guus Simons; Henri A Verbrugh; Alex van Belkum
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

5.  The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals.

Authors:  Rachel J Gordon; Nancy Chez; Haomiao Jia; Barbara Zeller; Magda Sobieszczyk; Caitlin Brennan; Katherine B Hisert; Mei-Ho Lee; Peter Vavagiakis; Franklin D Lowy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

6.  Determinants of acquisition and carriage of Staphylococcus aureus in infancy.

Authors:  Sharon J Peacock; Anita Justice; D Griffiths; G D I de Silva; M N Kantzanou; Derrick Crook; Karen Sleeman; Nicholas P J Day
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test.

Authors:  David P Kateete; Cyrus N Kimani; Fred A Katabazi; Alfred Okeng; Moses S Okee; Ann Nanteza; Moses L Joloba; Florence C Najjuka
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-08-13       Impact factor: 3.944

8.  Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users.

Authors:  M Miller; C Cespedes; P Vavagiakis; R S Klein; F D Lowy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-18       Impact factor: 3.267

9.  Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization in HIV infection: a meta-analysis.

Authors:  Fainareti N Zervou; Ioannis M Zacharioudakis; Panayiotis D Ziakas; Josiah D Rich; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

10.  Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells.

Authors:  Rebecca M Corrigan; Helen Miajlovic; Timothy J Foster
Journal:  BMC Microbiol       Date:  2009-01-30       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.